Laura Kleiman is Founder and CEO of Reboot Rx, the tech nonprofit dedicated to fast-tracking the development of affordable cancer treatments using repurposed generic drugs and AI technology. Laura’s career has focused on building collaborations across disciplines and sectors to expand treatment options for cancer patients. She was previously Scientific Research Director in the Department of Data Sciences at the Dana-Farber Cancer Institute. Laura earned a PhD in Computational and Systems Biology from MIT and conducted translational cancer research as an American Cancer Society Postdoctoral Fellow at the Massachusetts General Hospital and Harvard Medical School. Laura was recently featured in Forbes and received the 40 Under 40 in Cancer Award.
Laura joins me today to discuss not only her founder story but the role perseverance plays in all realms of a startup. She shares with us her experiences with fundraising as well as some of the challenges and advantages of choosing to be a tech non-profit.
“I'm passionate about bringing together different people towards a common goal. And in my case, I'm very focused on improving the lives of cancer patients through developing more effective and affordable drugs.” - Laura Kleiman
Today on Startups for Good we cover:
How to know if you have chosen the right co-founder
The implications of choosing tech non-profit status
Thanks for tuning into today’s episode of Startups For Good with your host, Miles Lasater. If you enjoyed this episode, please subscribe and leave a rating and review on your favorite podcast listening app.
Don’t forget to visit our website, connect with Miles on Twitter or LinkedIn, and share your favorite episodes across social media. For more information about The Giving Circle. Please share your feedback about the podcast on our listener survey pagehere.